The molecular mechanism studies suggest that CDK2/cyclin E and CDK4/cyclin D are involved in the inhibition of colon cancer cell proliferation by fargesin via p21WAF1/Cip1 and c-Myc, respectively. Here, CDK4 is linked to malignant colon neoplasm.